In vivo mitochondrial inhibition alters corticostriatal synaptic function and the modulatory effects of neurotrophins

Neuroscience

Volumn 280, Issue , 2014, Pages 156-170

  Mendoza, E ^a   Miranda Barrientos, J A ^a   Vazquez Roque R A ^b   Morales Herrera, E ^b   Ruelas, A ^a   De la Rosa, G ^a   Flores, G ^b   Hernandez Echeagaray E ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

Author keywords

3 NP; Dendrites; Mitochondria; Neurodegeneration; Neurotrophins; Striatum

Indexed keywords

3 NITROPROPIONIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; MESSENGER RNA; NEUROTRANSMITTER; NEUROTROPHIN 3; NEUROTROPHIN 3 RECEPTOR; NEUROTROPHIN 4; PROTEIN TYROSINE KINASE A; 3-NITROPROPIONIC ACID; GLUTAMIC ACID; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NITRO DERIVATIVE; PROPIONIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS STRIATUM; DENDRITE; DENDRITIC SPINE; HUNTINGTON CHOREA; IN VIVO STUDY; MALE; MEDIUM SPINY NEURON; MITOCHONDRION; MOUSE; NERVE CELL; NERVE CELL EXCITABILITY; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYNAPTIC TRANSMISSION; ANIMAL; C57BL MOUSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECTS; METABOLISM; NERVE TRACT; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; SYNAPSE; TISSUE CULTURE TECHNIQUE;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBRAL CORTEX; CORPUS STRIATUM; GLUTAMIC ACID; MALE; MICE, INBRED C57BL; MITOCHONDRIA; MITOCHONDRIAL DISEASES; NERVE GROWTH FACTORS; NEURAL PATHWAYS; NEUROTROPHIN 3; NITRO COMPOUNDS; PROPIONATES; RANDOM ALLOCATION; RECEPTORS, NERVE GROWTH FACTOR; SYNAPSES; SYNAPTIC TRANSMISSION; TISSUE CULTURE TECHNIQUES;

EID: 84907695054     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.09.018     Document Type: Article

References (65)

1. Acevedo-Torres K., Berríos L., Rosario N., Dufault V., Skatchkov S., Eaton M.J., Torres-Ramos C.A., Ayala-Torres S. Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease. DNA Repair 2009, 8:126-136.
2. Alberch J., Perez-Navarro E., Canals J.M. Neurotrophic factors in Huntington's disease. Prog Brain Res 2004, 146:195-229.
3. Alquicer G., Morales-Medina J.C., Quirion R., Flores G. Postweaning social isolation enhances morphological changes in the neonatal ventral hippocampal lesion rat model of psychosis. J Chem Neuroanat 2008, 35:179-187.
4. Alston T.A., Mela L., Bright H.J. Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc Natl Acad Sci 1977, 74:3767-3771.
5. Ambacher K.K., Pitzul K.B., Karajgikar M., Hamilton A., Ferguson S.S., Cregan S.P. The JNK- and AKT/GSK3β-signaling pathways converge to regulate puma induction and neuronal apoptosis induced by trophic factor deprivation. PLoS One 2012, 7(10):e46885.
6. Brouillet E., Hantraye P., Ferrante R.J., Dolan R., Leroy-Willig A., Kowall N.W., Beal M.F. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci 1995, 92:7105-7109.
7. Brouillet E., Jacquard C., Bizat N., Blum D. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J Neurochem 2005, 95:1521-1540.
8. Calabresi P., Gubellini P., Picconi B., Centonze D., Pisani A., Bonsi P., Greengard P., Hipskind R.A., Borrelli E., Bernardi G. Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. J Neurosci 2001, 21:5110-5120.
9. Carmignoto G., Pizzorusso T., Tia S., Vicini S. Brain-derived neurotrophic factor and nerve growth factor potentiate excitatory synaptic transmission in the rat visual cortex. J Physiol 1997, 498:153-164.
10. Chapleau C.A., Pozzo-Miller L. Divergent roles of p75NTR and Trk receptors in BDNF's effects on dendritic spine density and morphology. Neural Plast 2012, 578057.
11. Cho D.H., Nakamura T., Lipton S.A. Mitochondrial dynamics in cell death and neurodegeneration Cell. Mol Life Sci 2010, 67:3435-3447.
12. Coles C.J., Edmondson D.E., Singer T.P. Inactivation of succinate dehydrogenase by 3-nitropropionate. J Biol Chem 1979, 254:5161-5167.
13. 2+ uptake prevents desynchronization of quantal release and minimizes depletion during repetitive stimulation of mouse motor nerve terminals. J Physiol 2003, 548:425-438.
14. Di Filippo M., Tozzi A., Tantucci M., Arcangeli S., Chiasserini D., Ghiglieri V., de Iure A., Calabresi P. Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: electrophysiological evidence. Neurobiol Dis 2013, 62:387-393.
15. Espíndola S., Vilches A., Hernández-Echeagaray E. 3-Nitropropionic acid modifies neurotrophin mRNA expression in the mouse striatum: 18S-rRNA is a reliable control gene for studies of the striatum. Neurosci Bull 2012, 28:517-531.
16. Fernandes H.B., Baimbridge K.G., Church J., Hayden M.R., Raymond L.A. Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease. J Neurosci 2007, 27:13614-13623.
17. Ferrante R.J., Kowall N.W., Richardson E.P. Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. J Neurosci 1991, 12:3877-3887.
18. Flores G., Alquicer G., Silva-Gomez A.B., Zaldivar G., Stewart J., Quirion R., Srivastava L.K. Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neurosci 2005, 133:463-470.
19. Frazier A.E., Kiu C., Stojanovski D., Hoogenraad N.J., Ryan M.T. Mitochondrial morphology and distribution in mammalian cells. Biol Chem 2006, 387:1551-1558.
20. Giralt A., Carretón O., Lao-Peregrin C., Martín E.D., Alberch J. Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction. Mol Neurodegen 2011, 6:71.
21. Gould D.H., Gustine D.L. Basal ganglia degeneration, myelin alterations, and enzyme inhibition induced in mice by the plant toxin 3-nitropropanoic acid. Neuropathol Appl Neurobiol 1982, 8:377-393.
22. Gu M., Gash M.T., Mann V.M., Javoy-Agid F., Cooper J.M., Schapira A.H. Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol 1996, 39:385-389.
23. Gubellini P., Centonze D., Tropepi D., Bernardi G., Calabresi P. Induction of corticostriatal LTP by 3-nitropropionic acid requires the activation of mGluR1/PKC pathway. Neuropharmacology 2004, 46:761-769.
24. Guo Z.H., Mattson M.P. Neurotrophic factors protect cortical synaptic terminals against amyloid and oxidative stress-induced impairment of glucose transport, glutamate transport and mitochondrial function. Cereb Cortex 2000, 10:50-57.
25. Hernández-Echeagaray E., Galarraga E., Bargas J. 3-α-Chloro-imperialine, a potent blocker of cholinergic presynaptic. Neuropharmacology 1998, 37:1493-1502.
26. Hollenbeck P.J. Mitochondria and neurotransmission: evacuating the synapse. Neuron 2005, 47:331-333.
27. Juárez J., Gratton A., Flores A. Ontogeny of altered dendritic morphology in the rat prefrontal cortex, hippocampus and nucleus accumbens following Caesarean delivery and birth anoxia. J Comp Neurol 2008, 507:1734-1747.
28. Johnston D., Wu S.M.S. Foundations of cellular neurophysiology 1995, The MIT Press, Cambridge.
29. 2+ and short-term synaptic plasticity. Nat 1994, 371:603-606.
30. Kann O., Kovacs R. Mitochondria and neuronal activity. Am J Physiol Cell Physiol 2007, 292:641-657.
31. Katz B., Miledi R. The role of calcium in neuromuscular facilitation. J Physiol 1968, 195:481-492.
32. Kells A.P., Fong D.M., Dragunow M., During M.J., Young D., Connor B. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease. Mol Ther 2004, 9:682-688.
33. Klapstein G.J., Fisher R.S., Zanjani H., Cepeda C., Jokel E.S., Chesselet M.F., Levine M.S. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J Neurophysiol 2001, 86:2667-2677.
34. Leßmann V., Heumann R. Modulation of unitary glutamatergic synapses by neurotrophin-4/5 or brain-derived neurotrophic factor in hippocampal microcultures: presynaptic enhancement depends on pre-established paired-pulse facilitation. Neuroscience 1998, 86:399-413.
35. Li Z., Okamoto K., Hayashi Y., Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004, 119:873-887.
36. Lu C., Fu W., Mattson M.P. Direct cleavage of AMPA receptor subunit GluR1 and suppression of AMPA currents by caspase-3: implications for synaptic plasticity and excitotoxic neuronal death. Neuro Mol Med 2002, 1:69-79.
37. Ly C.V., Verstreken P. Mitochondria at the synapse. Neuroscientist 2006, 12:291-299.
38. Malenka R.C., Kocsis J.D. Presynaptic actions of carbachol and adenosine on corticostriatal synaptic transmission in vitro. J Neurosci 1988, 8:3750-3756.
39. Martínez-Téllez R.I., Hernández-Torres E., Gamboa C., Flores G. Prenatal stress alters spine density and dendritic length of nucleus accumbens and hippocampus neurons in rat offspring. Synapse 2009, 63:794-804.
40. McBride J.L., During M.J., Wuu J., Chen E.Y., Leurgans S.E., Kordower J.H. Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF. Exp Neurol 2003, 181:213-223.
41. Ming L. Moldy sugarcane poisoning-a case report with a brief review. J Toxicol Clin Toxicol 1995, 33:363-367.
42. Monroy E., Hernández-Torres E., Flores G. Maternal separation disrupts dendritic morphology of neurons in prefrontal cortex, hippocampus, and nucleus accumbens in male rat offspring. J Chem Neuroanat 2010, 40:93-101.
43. Morales-Medina J.C., Mejorada A., Romero-Curiel A., Flores G. Alterations in dendritic morphology of hippocampal neurons in adult rats after neonatal administration of N-omega-nitro-L-arginine. Synapse 2007, 61:785-789.
44. Morales-Medina J.C., Sanchez F., Flores G., Dumont Y., Quirion R. Morphological reorganization after repeated corticosterone administration in the hippocampus, nucleus accumbens and amygdala in the rat. J Chem Neuroanat 2009, 38:266-272.
45. Nikoletopoulou V., Lickert H., Frade J.M., Rencurel C., Giallonardo P., Zhang L., Bibel M., Barde Y.A. Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature 2010, 467:59-63.
46. Nishino H., Hida H., Kumazaki M., Shimano Y., Nakajima K., Shimizu H., Oiwa T., Baba H. The striatum is the most vulnerable region in the brain to mitochondrial energy compromise: a hypothesis to explain its specific vulnerability. J Neurotrauma 2000, 17:251-260.
47. Oliveira J.M., Jekabsons M.B., Chen S., Lin A., Rego A.C., Goncalves J., Ellerby L.M., Nicholls D.G. Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice. J Neurochem 2007, 101:241-249.
48. Palfi S., Ferrante R.J., Brouillet E., Beal M.F., Dolan R., Guyot M.C., Peschanski M., Hantraye P. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. J Neurosci 1996, 16:3019-3025.
49. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, San Diego. 2nd ed.
50. Pérez-Navarro E., Canudas A.M., Akerund P., Alberch J., Arenas E. Brain-derived neurotrophin factor, neurotrophin-3 and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease. J Neurochem 2000, 75:2190-2199.
51. Pickrell A.M., Fukui H., Wang X., Pinto M., Moraes C.T. The striatum is highly susceptible to mitochondrial oxidative phosphorylation dysfunctions. J Neurosci 2011, 31:9895-9904.
52. Reddy P.H., Mao P., Manczak M. Mitochondrial structural and functional dynamics in Huntington's disease. Brain Res Rev 2009, 61:33-48.
53. Schulz P.E., Cook E.P., Johnston D. Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation. J Neurosci 1994, 14:5325-5337.
54. Schulz J.B., Henshaw D.R., MacGarvey U., Beal M.F. Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity. Neurochem Int 1996, 29:167-171.
55. Sholl D.A. Dendritic organization in the neurons of the visual and motor cortices of the cat. J Anat 1953, 1953(87):387-406.
56. Silva-Gomez A.B., Rojas D., Juarez I., Flores G. Decreased dendritic spine density on prefrontal cortical and hippocampal pyramidal neurons in postweaning social isolation rats. Brain Res 2003, 983:128-136.
57. Stewart R.R., Adams W.B., Nicholls J.G. Presynaptic calcium currents and facilitation of serotonin release at synapses between cultured leech neurons. J Exp Biol 1989, 144:1-12.
58. Suen P.C., Wu K., Levine E.S., Mount H.T., Xu J.L., Lin S.Y., Black I.B. Brain-derived neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N-methyl-d-aspartate receptor subunit 1. PNAS 1997, 94:8191-8195.
59. Tabrizi S.J., Workman J., Hart P.E., Mangiarini L., Mahal A., Bates G., Cooper J.M., Schapira A.H. Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse. Ann Neurol 2000, 47(1):80-86.
60. Tauszig-Delamasure S., Yu L.Y., Cabrera J.R., Bouzas-Rodriguez J., Mermet-Bouvier C., Guix C., Bordeaux M.C., Arumaë U., Mehlen P. The TrkC receptor induces apoptosis when the dependence receptor notion meets the neurotrophin paradigm. PNAS 2007, 104:13361-13366.
61. Tong J.J. Mitochondrial delivery is essential for synaptic potentiation. Biol Bull 2007, 212:169-175.
62. Tyler W.J., Pozzo-Miller L.D. BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses. J Neurosci 2001, 21:4249-4258.
63. Wu C.L., Chen S.D., Hwang C.S., Yang D.I. Sonic hedgehog mediates BDNF-induced neuroprotection against mitochondrial inhibitor 3-nitropropionic acid. Biochem Biophys Res Comm 2009, 385:112-117.
64. Zermeño V., Espíndola S., Mendoza E., Hernández-Echeagaray E. Differential expression of neurotrophins in postnatal C57BL/6 mice striatum. Int J Biol Sci 2009, 5:118-127.
65. Zuccato C., Cattaneo E. Role of brain-derived neurotrophic factor in Huntington's disease. Prog Neurobiol 2007, 81:294-330.